PMC:7152526 / 236-342
Annnotations
LitCovid-PD-FMA-UBERON
{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T2","span":{"begin":34,"end":40},"obj":"Body_part"}],"attributes":[{"id":"A2","pred":"fma_id","subj":"T2","obj":"http://purl.org/sig/ont/fma/fma62970"}],"text":"d its treatment, but convalescent plasma has been expected to increase survival rates as in the case with "}
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T3","span":{"begin":34,"end":40},"obj":"http://purl.obolibrary.org/obo/UBERON_0001969"},{"id":"T4","span":{"begin":41,"end":44},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"}],"text":"d its treatment, but convalescent plasma has been expected to increase survival rates as in the case with "}
LitCovid-PMC-OGER-BB
{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T8","span":{"begin":34,"end":40},"obj":"UBERON:0001969"},{"id":"T71695","span":{"begin":34,"end":40},"obj":"UBERON:0001969"}],"text":"d its treatment, but convalescent plasma has been expected to increase survival rates as in the case with "}